{
    "body": "Which forms of cancer is the Tpl2 gene associated with?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/15575964", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23457529", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23064365", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21267413", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20935675", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22451924"
    ], 
    "triples": [
        {
            "p": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseasome/associatedGene", 
            "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/3003", 
            "o": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/genes/TPL2"
        }
    ], 
    "ideal_answer": [
        "Tpl2/Map3K8, also known as tumor progression locus 2 has been identified as an oncogene, its mutation or overexpression is reported in a variety of human cancers. Types of cancer associated with Tpl2 include skin and epithelial cancers, ADI prostate cancer, gastric and colon adenocarcinomas, colitis-associated cancer (CAC), breast cancer, Hodgkin lymphomas, nasopharyngeal carcinomas and several types of T-cell neoplasias."
    ], 
    "exact_answer": [
        [
            "Skin cancer"
        ], 
        [
            "ADI prostate cancer"
        ], 
        [
            "gastric adenocarcinoma"
        ], 
        [
            "colon adenocarcinoma"
        ], 
        [
            "colitis-associated cancer (CAC)"
        ], 
        [
            "breast cancer"
        ], 
        [
            "Hodgkin lymphoma"
        ], 
        [
            "nasopharyngeal carcinoma"
        ], 
        [
            "T-cell neoplasia"
        ]
    ], 
    "concepts": [
        "http://www.disease-ontology.org/api/metadata/DOID:162", 
        "http://www.uniprot.org/uniprot/M3K8_RAT"
    ], 
    "type": "list", 
    "id": "515bf6d6298dcd4e51000004", 
    "snippets": [
        {
            "offsetInBeginSection": 1344, 
            "offsetInEndSection": 1485, 
            "text": "These findings establish a mesenchyme-specific role for Tpl2 in the regulation of HGF production and suppression of epithelial tumorigenesis.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23064365", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 96, 
            "text": "Tpl2 regulates intestinal myofibroblast HGF release to suppress colitis-associated tumorigenesis", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23064365", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 64, 
            "text": "Tpl2 ablation promotes intestinal inflammation and tumorigenesis", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22451924", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 113, 
            "text": "Loss of tumor progression locus 2 (tpl2) enhances tumorigenesis and inflammation in two-stage skin carcinogenesis", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20935675", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 170, 
            "offsetInEndSection": 281, 
            "text": " Previously identified as an oncogene, its mutation or overexpression is reported in a variety of human cancers", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20935675", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 1189, 
            "offsetInEndSection": 1390, 
            "text": "These studies indicate that Tpl2 may serve more as a tumor suppressor than as an oncogene in chemically induced skin carcinogenesis, with its absence contributing to both tumorigenesis and inflammation", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20935675", 
            "endSection": "sections.0"
        }
    ]
}